Connecting with colleagues in person allows for meaningful conversations about the future of the retina care field and patients, said Steven Yeh, MD, professor and the Stanley Truhlsen Jr. Chair in Ophthalmology at the Truhlsen Eye Institute, University of Nebraska Medical Center.
Connecting with colleagues in person allows for meaningful conversations about the future of the retina care field and patients, said Steven Yeh, MD, professor and the Stanley Truhlsen Jr. Chair in Ophthalmology at the Truhlsen Eye Institute, University of Nebraska Medical Center.
Transcript
What are you looking forward to at the 40th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS)?
I'm really excited about the ASRS meeting in just a couple of days from now in New York City and really to connect with colleagues to have conversations about important clinical trial data that will be coming out, including data on age-related macular degeneration, diabetic retinopathy, and uveitis. And more importantly, that face-to-face conversation is just so meaningful thinking about the future of our field, both for retina care and for uveitis, for our patients.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS
January 13th 2025A pair of abstracts presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exhibition suggest that IDH1-targeted treatment may improve survival among patients with myelodysplastic syndromes (MDS) with the mutation.
Read More